Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc1851 p53 acetylation Lys382 human Lung Cancer A549 MS-275 Associated 4.0 (Moderate) 36257192
acc1852 SKP2 acetylation Lys68 human Prostate Cancer LNCaP Dihydrotestosterone Associated 4.0 (Moderate) 36871351
acc1853 SKP2 acetylation Lys71 human Prostate Cancer LNCaP Dihydrotestosterone Associated 4.0 (Moderate) 36871351
acc1854 SKP2 acetylation Lys68 human Prostate Cancer C4-2 Dihydrotestosterone Associated 4.0 (Moderate) 36871351
acc1855 SKP2 acetylation Lys71 human Prostate Cancer C4-2 Dihydrotestosterone Associated 4.0 (Moderate) 36871351
acc1856 histone H3 methylation Lys9 human Colorectal Cancer SW480 Mithramycin Associated 3.0 (Low) 32473242
acc1857 histone H3 methylation Lys9 human Colorectal Cancer LoVo Mithramycin Associated 3.0 (Low) 32473242
acc1858 AKT phosphorylation Ser473 human Colorectal Cancer SW480 Cetuximab Impairing 5.0 (High) 32473242
acc1859 AKT phosphorylation Ser473 human Colorectal Cancer LoVo Cetuximab Impairing 5.0 (High) 32473242
acc1860 AKT phosphorylation Tyr308 human Colorectal Cancer SW480 Cetuximab Impairing 5.0 (High) 32473242
acc1861 AKT phosphorylation Tyr308 human Colorectal Cancer LoVo Cetuximab Impairing 5.0 (High) 32473242
acc1862 MST1 methylation Lys59 human Breast Cancer MDA-MB-231 Neuregulin Associated 4.0 (Moderate) 28114269
acc1863 HER3 phosphorylation Tyr1307 human Breast Cancer MDA-MB-231 Neuregulin Associated 4.0 (Moderate) 28114269
acc1864 HSP70 methylation Arg416 human Pancreas Cancer MIA PaCa-2 Gemcitabine Impairing 5.0 (High) 32699135
acc1865 HSP70 methylation Arg447 human Pancreas Cancer MIA PaCa-2 Gemcitabine Impairing 5.0 (High) 32699135
acc1866 ULK1 methylation Arg170 human Lung Cancer A549 Carboplatin Impairing 5.0 (High) 37381616
acc1867 ULK1 methylation Arg170 human Lung Cancer NCI-H1975 Carboplatin Impairing 5.0 (High) 37381616
acc1868 RNF4 methylation Arg164 human Leukemia NB-4 As2O3 Impairing 5.0 (High) 35622143
acc1869 mTOR phosphorylation Ser2448 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1870 mTOR phosphorylation Ser2448 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1871 4EBP1 phosphorylation Thr46 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1872 4EBP1 phosphorylation Thr46 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1873 ERK1 phosphorylation Thr202 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1874 ERK1 phosphorylation Thr202 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1875 ERK1 phosphorylation Thr202 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1876 ERK1 phosphorylation Tyr204 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1877 ERK1 phosphorylation Tyr204 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1878 ERK1 phosphorylation Tyr204 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1879 ERK2 phosphorylation Thr185 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1880 ERK2 phosphorylation Thr185 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1881 mTOR phosphorylation Ser2448 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1882 ERK2 phosphorylation Thr185 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1883 ERK2 phosphorylation Tyr187 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1884 ERK2 phosphorylation Tyr187 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1885 ERK2 phosphorylation Tyr187 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1886 p70s6K phosphorylation Thr389 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1887 p70s6K phosphorylation Thr389 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1888 p70s6K phosphorylation Thr389 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1889 4EBP1 phosphorylation Thr37 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1890 4EBP1 phosphorylation Thr37 human Colorectal Cancer HT29 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1891 4EBP1 phosphorylation Thr37 human Colorectal Cancer HCT116 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1892 4EBP1 phosphorylation Thr46 human Colorectal Cancer SW480 PD98059 + Rapamycin Associated 4.0 (Moderate) 19194827
acc1893 mTOR phosphorylation Ser2448 human Pancreas Cancer CFPAC-1 Pralatrexate Associated 4.0 (Moderate) 36544829
acc1894 4EBP1 phosphorylation Thr37 human Pancreas Cancer CFPAC-1 Pralatrexate Associated 4.0 (Moderate) 36544829
acc1895 4EBP1 phosphorylation Thr46 human Pancreas Cancer CFPAC-1 Pralatrexate Associated 4.0 (Moderate) 36544829
acc1896 mTOR phosphorylation Ser2448 human Pancreas Cancer BxPC-3(gemcitabine R) Pralatrexate Associated 4.0 (Moderate) 36544829
acc1897 4EBP1 phosphorylation Thr37 human Pancreas Cancer BxPC-3(gemcitabine R) Pralatrexate Associated 4.0 (Moderate) 36544829
acc1898 4EBP1 phosphorylation Thr46 human Pancreas Cancer BxPC-3(gemcitabine R) Pralatrexate Associated 4.0 (Moderate) 36544829
acc1899 CUL1 neddylation unclear human Lung Cancer H1299 MLN4924 Impairing 5.0 (High) 31208947
acc1900 CUL2 neddylation unclear human Lung Cancer H1299 MLN4924 Impairing 5.0 (High) 31208947